2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
A Standard patent application filed on 13 November 2002 credited to Borthwick, Alan David ; Mason, Andrew Mcmurtrie ; Chan, Chuen ; Kelly, Henry Anderson ; Campbell, Matthew ; Senger, Stefan ; Watson, Nigel Stephen ; Smith, Paul William ; Young, Robert John ; Kleanthous, Savvas ; King, Nigel Paul

Details

Application number :

2002339158  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors  

Inventor :

Borthwick, Alan David ; Mason, Andrew Mcmurtrie ; Chan, Chuen ; Kelly, Henry Anderson ; Campbell, Matthew ; Senger, Stefan ; Watson, Nigel Stephen ; Smith, Paul William ; Young, Robert John ; Kleanthous, Savvas ; King, Nigel Paul  

Agent name :

 

Address for service :

 

Filing date :

13 November 2002  

Associated companies :

 

Applicant name :

GLAXO GROUP LIMITED  

Applicant address :

Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN  

Old name :

 

Original Source :

Go